INUFUSA INTERNATIONAL SYMPOSIUM
On Oxidative Stress for Sustainable Development of Human Beings (5th Intl. Symp.)

Bio | CV | Publications
This major symposium is in honor of the distinguished work and lifetime achievements of Dr. Haruhiko Inufusa, a very well-known professional with deep impact in oxidative stress for sustainable development of human beings.
Dr. Haruhiko Inufusa was born Okayama Japan at 1957. After finished Medical School Kindai University at 1982, he starts work at Surgery department of Kindai University Hospital. At the period of post graduate school of Kindai University, he started research of cancer especially on metastasis phenomenon. He established various cancer cell lines, and one cell line had potential of metastasis in nude mouse. He achieved principal graduation by this research result at 1988. Cancer and glycolipid was his main research target during his post doctor fellowship position 1988-1990 at University Washington Seattle, Professor Sen-itchiro Hakomori laboratory,. Later, he found that Lewis Y glycolipid of cancer controls blood coagulation and metastasis as well.
In 2001, he was promoted professor at Kindai University School of Medicine (Department of Surgery) and Faculty of Agriculture (Department of Clinical Nutrition). Acting as a surgeon, he was one of first 15 doctors in Japan who started laparoscopic surgery for colorectal cancer, and his surgical video was widely used to educate young doctors.
In 2006 he resigned from his position of Director of Advanced Medical Technology and Medical Economics, at Kindai University School of Medicine. He starts research on alcohol, sugar, and fat metabolism at TIMA Japan Inc. which supported by TIMA foundation. After invention of anti-alcohol supplement SUPLAIV, he invented Twendee X that activate sugar and fat metabolisms. Strong anti-oxidant effects of Twendee X were found at 2011, he starts producing and marketing SUPAILV and Twendee X by the request of TIMA foundation. At 2013, Gifu university started his laboratory Division of Antioxidant Research. His present main invention is the successful treatment of various patients with Twendee X.
ROUND TABLE DISCUSSIONS
A round table discussion open to everyone interested will be organized during the symposium. This will allow high level representatives of various industries, technologies, and academic disciplines to discuss and debate freely, without reservations, all topics of this symposium and identify possible research and development pathways towards a future industry with increased sustainability. Click here for a description of the topics of symposium and the round table.
You are cordially invited to actively participate in this symposium by submitting and presenting a paper, or by attending the round table. We look forward to meeting you at this world class symposium.
Click here to see the detailed scope and topics.To download Flyer, click on the icon:
Click here to see the General Author Invitation: https://www.flogen.org/sips2025/invitations/Oxidative_General_Author_Invitation.htmlClick here to see the Social Media Text: https://www.flogen.org/sips2025/socialmediatext/Oxidative_Social_Media_Text.htmlClick here to see other resources for this symposium: https://www.flogen.org/sips2025/symresources.php?sym=54CHAIRS
Dr. Florian
KongoliCEO/President
FLOGEN TechnologiesCanada,
[Bio]
Dr. Koji
AbeProfessor
Okayama U.Japan,
[Bio]
Dr. Koji
FukuiProfessor
Shibaura Inst. of TechnologyJapan,
[Bio]
Dr. Shigeru
HiranoMedical Doctor, Professor
Kyoto Prefectural U. of MedicineJapan,
[Bio]
Davis
JosephResearcher
McGill U.Canada,
[Bio]